12 September 2016 - The time, an explanation from The Economist.

“Drugs have been marketed at such extraordinarily high prices that many people will simply not be able to afford them,” wrote a top cancer doctor in a scathing editorial in the Washington Post. That was in 2004. More than a decade later, the cost of drugs in America is still soaring—the most recent uproar was sparked by the price of Mylan’s EpiPen allergy medicine, which has jumped by about 600% since 2007. Despite the furore, drug companies continue to charge exorbitant prices in America. Why?

Read The Economist article